Inventor

COLLIER SIERRA JONES

US13 patents

⚠️ This page may combine multiple inventors who share the name “COLLIER SIERRA JONES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LABRYS BIOLOG INC

8 patents

US8734802B1May 27, 2014

Methods of treating vasomotor symptoms using antibodies

LABRYS BIOLOG INC54 citations98

US8597649B2Dec 3, 2013

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

LABRYS BIOLOG INC51 citations98

US9266951B2Feb 23, 2016

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

LABRYS BIOLOG INC23 citations96

US9115194B2Aug 25, 2015

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

LABRYS BIOLOG INC26 citations96

US9365648B1Jun 14, 2016

Methods of using anti-CGRP antagonist antibodies

LABRYS BIOLOG INC16 citations92

US9346881B2May 24, 2016

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

LABRYS BIOLOG INC16 citations92

US9340614B2May 17, 2016

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

LABRYS BIOLOG INC16 citations92

US9328168B2May 3, 2016

Methods of using anti-CGRP antagonist antibodies

LABRYS BIOLOG INC16 citations92

TEVA PHARMACEUTICALS INT GMBH

5 patents

US9890211B2Feb 13, 2018

Antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INT GMBH11 citations92

US9890210B2Feb 13, 2018

Antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INT GMBH11 citations92

US9884907B2Feb 6, 2018

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INT GMBH15 citations92

US9884908B2Feb 6, 2018

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INT GMBH15 citations92

US10329343B2Jun 25, 2019

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INT GMBH5 citations84